OliX Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.7%.

Top 19 shareholders own 35.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.3%	Dong-Ki Lee	3,504,258	₩73.9b	-0.04%	no data
5.39%	Mirae Asset Global Investments Co., Ltd.	930,000	₩19.6b	0%	0.01%
4.99%	National Pension Service	860,000	₩18.1b	0%	0.01%
1.02%	Kiwoom Investment Co., Ltd.	175,324	₩3.7b	0%	13.7%
1.01%	AJU IB INVESTMENT Co., Ltd.	173,402	₩3.7b	0%	4.27%
0.98%	PineBridge Investments LLC	168,933	₩3.6b	4.64%	0.01%
0.49%	JP Morgan Asset Management	83,949	₩1.8b	0%	no data
0.35%	Chung-Gil Kang	60,000	₩1.3b	0%	no data
0.23%	Shin-Yeong Park	40,000	₩844.0m	0%	no data
0.2%	Norges Bank Investment Management	34,609	₩730.3m	0%	no data
0.15%	The Vanguard Group, Inc.	26,486	₩558.9m	-92.8%	no data
0.042%	Dimensional Fund Advisors LP	7,163	₩151.1m	0%	no data
0.03%	State Street Global Advisors, Inc.	5,163	₩108.9m	-1%	no data
0.007%	Yang-gyun Kim	1,200	₩25.3m	0%	no data
0.004%	KB Asset Management Co., Ltd.	687	₩14.5m	0%	no data
0.0013%	Samsung Asset Management Company, Ltd.	217	₩4.6m	0%	no data
0.00052%	Kiwoom Asset Management Co., Ltd.	89	₩1.9m	0%	0.01%
0.0005%	NH Investment & Securities Co., Ltd., Asset Management Arm	87	₩1.8m	0%	no data
0.00045%	NH-Amundi Asset Management	78	₩1.6m	0%	no data